University of Thessaly (UTH)
Μοριακή ανάλυση του μεταβολισμού του σιδήρου και άλλων χαρακτηριστικών μορίων στη μυελική και λεμφική σειρά
Abstract
dc:descriptionIn the present thesis, we evaluated mRNA and protein expression of several molecules critical for B cell function (CD23, CD25, CD27, CD38, CD79b, CD71 and TfR2) in CD19+ B cells from 10 normal donors and 95 CLL patients. We also investigated the mechanisms regulating the expression of the above mentioned surface antigens and their possible differences between normal and leukemic B cells. Moreover, we tried to assess any possible association between antigen expression and clinical or biological parameters, such as disease clinical stage, chromosomal abnormalities and IGHV gene mutational status. In CLL, surface antigens CD23, CD25, CD38, CD79b and transferrin receptors TfR1 and TfR2 showed great divergence in both mRNA (analysed by Real-Time PCR) and protein (analysed by Western Blotting) levels; no mRNA and protein levels correlation could be discerned. Protein expression was irrelevant to their corresponding mRNA levels, thus indicating post-transcriptional mechanisms regulating CD23, CD25, CD38, CD79b, CD71 and TfR2 expression in CLL B cells. To further investigate the mechanisms regulating transferrin receptors gene expression, CLL B cells were cultured in the presence of actinomycin D and cycloheximide. This treatment did not affect TfR1/TfR2 mRNA expression, indicating predominantly posttranscriptional regulation. CD27 presents different expression pattern with mRNA and protein levels linear correlation, indicating transcriptional mechanisms regulating CD27 expression in CLL B cells. Analysis of possible correlations between mRNA and/or surface protein expression and clinico-biological parameters revealed significantly higher CD38 mRNA levels in CLL patients of advanced stages compared to Binet stage A patients. CD23, CD25, CD79b, CD27, CD71 and TfR2 expression showed no correlation with clinical stage at diagnosis. Moreover, patients with trisomy 12 showed 2-fold higher CD79b protein levels and higher CD27 mRNA levels, in contrast to patients with normal karyotype. CD23, CD25, CD38, CD71 and TfR2 expression showed no correlation with trisomy 12 or deletion 13q. Patients with unmutated IGHV sequences showed higher CD38 mRNA and CD79b protein levels and quite lower CD25 mRNA levels compared to patients with mutated sequences. Finally, CD23, CD27, CD71 and TfR2 showed similar expression, regardless IGHV gene mutations. In normal CD19+ B cells, CD23 and CD79b mRNA levels showed great divergence, with no correlation between mRNA and protein levels. CD38 and CD25 mRNA levels showed minor divergence among different donors, while the corresponding proteins were not detected in normal B cells under study. CD27 mRNA levels were quite high in all normal samples, in accordance to their protein levels. TfR1/2 mRNA and protein expression showed direct correlation and limited variation among normal B cells, contrary to CLL samples. Treatment of normal B cells with actinomycin D and cycloheximide designated the transcriptional regulation of both TfR1/TfR2 expression. Finally, CD23 and CD79b expression seems to be mainly regulated by post-transcriptional mechanisms, whereas CD25, CD27 and CD38 expression appears to be regulated by transcriptional mechanisms.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chiotoglou, Ioanna
- Χιωτόγλου, Ιωάννα
Subjects
dc:subject × 15- Χρόνια λεμφοκυτταρική λευχαιμία (ΧΛΛ)
- Φυσιολογικ΄λα Β λεμφοκύτταρα
- Μόρια κυτταρικής ενεργοποίησης
- Μηχανισμοί ρύθμισης γονιδιακής έκφρασης
- Υποδοχείς τρανσφερρίνης
- Chronic lymphocytic leukemia
- CD23
- CD25
- CD27
- CD38
- CD79b
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26201